Race/Ethnicity, Spirometry Reference Equations, and Prediction of Incident Clinical Events: The Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study
- PMID: 34913853
- DOI: 10.1164/rccm.202107-1612OC
Race/Ethnicity, Spirometry Reference Equations, and Prediction of Incident Clinical Events: The Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study
Abstract
Rationale: Normal values for FEV1 and FVC are currently calculated using cross-sectional reference equations that include terms for race/ethnicity, an approach that may reinforce disparities and is of unclear clinical benefit. Objectives: To determine whether race/ethnicity-based spirometry reference equations improve the prediction of incident chronic lower respiratory disease (CLRD) events and mortality compared with race/ethnicity-neutral equations. Methods: The MESA Lung Study, a population-based, prospective cohort study of White, Black, Hispanic, and Asian adults, performed standardized spirometry from 2004 to 2006. Predicted values for spirometry were calculated using race/ethnicity-based equations following guidelines and, alternatively, race/ethnicity-neutral equations without terms for race/ethnicity. Participants were followed for events through 2019. Measurements and Main Results: The mean age of 3,344 participants was 65 years, and self-reported race/ethnicity was 36% White, 25% Black, 23% Hispanic, and 17% Asian. There were 181 incident CLRD-related events and 547 deaths over a median of 11.6 years. There was no evidence that percentage predicted FEV1 or FVC calculated using race/ethnicity-based equations improved the prediction of CLRD-related events compared with those calculated using race/ethnicity-neutral equations (difference in C statistics for FEV1, -0.005; 95% confidence interval [CI], -0.013 to 0.003; difference in C statistic for FVC, -0.008; 95% CI, -0.016 to -0.0006). Findings were similar for mortality (difference in C statistics for FEV1, -0.002; 95% CI, -0.008 to 0.003; difference in C statistics for FVC, -0.004; 95% CI, -0.009 to 0.001). Conclusions: There was no evidence that race/ethnicity-based spirometry reference equations improved the prediction of clinical events compared with race/ethnicity-neutral equations. The inclusion of race/ethnicity in spirometry reference equations should be reconsidered.
Keywords: chronic lower respiratory disease; pulmonary function tests; race/ethnicity–based reference equations; racism; spirometry.
Comment in
-
The Vanishing Rationale for the Race Adjustment in Pulmonary Function Test Interpretation.Am J Respir Crit Care Med. 2022 Mar 15;205(6):612-614. doi: 10.1164/rccm.202112-2772ED. Am J Respir Crit Care Med. 2022. PMID: 35085469 No abstract available.
-
Race/Ethnicity and Reference Equations for Spirometry.Am J Respir Crit Care Med. 2022 Sep 15;206(6):790-792. doi: 10.1164/rccm.202201-0197LE. Am J Respir Crit Care Med. 2022. PMID: 35503241 Free PMC article. No abstract available.
-
U.S. Occupational Historical Perspective on Race and Lung Function.Am J Respir Crit Care Med. 2022 Sep 15;206(6):789-790. doi: 10.1164/rccm.202203-0565LE. Am J Respir Crit Care Med. 2022. PMID: 35503517 Free PMC article. No abstract available.
-
Reply by Elmaleh-Sachs et al. to Townsend and Cowl, and to Miller et al.Am J Respir Crit Care Med. 2022 Sep 15;206(6):792-795. doi: 10.1164/rccm.202204-0628LE. Am J Respir Crit Care Med. 2022. PMID: 35503649 Free PMC article. No abstract available.
Similar articles
-
Application of Global Lung Function Initiative Global Spirometry Reference Equations across a Large, Multicenter Pulmonary Function Lab Population.Am J Respir Crit Care Med. 2024 Jan 1;209(1):83-90. doi: 10.1164/rccm.202303-0613OC. Am J Respir Crit Care Med. 2024. PMID: 37523681 Free PMC article.
-
Changes in interpretation of spirometry by implementing the GLI 2012 reference equations: impact on patients tested in a hospital-based PFT lab in a large metropolitan city.BMJ Open Respir Res. 2022 Dec;9(1):e001389. doi: 10.1136/bmjresp-2022-001389. BMJ Open Respir Res. 2022. PMID: 36600407 Free PMC article.
-
Spirometry Interpretation After Implementation of Race-Neutral Reference Equations in Children.JAMA Pediatr. 2024 Jul 1;178(7):699-706. doi: 10.1001/jamapediatrics.2024.1341. JAMA Pediatr. 2024. PMID: 38805209
-
Race Adjustment of Pulmonary Function Tests in the Diagnosis and Management of COPD: A Scoping Review.Int J Chron Obstruct Pulmon Dis. 2024 Apr 29;19:969-980. doi: 10.2147/COPD.S430249. eCollection 2024. Int J Chron Obstruct Pulmon Dis. 2024. PMID: 38708410 Free PMC article. Review.
-
Addressing Race in Pulmonary Function Testing by Aligning Intent and Evidence With Practice and Perception.Chest. 2022 Jan;161(1):288-297. doi: 10.1016/j.chest.2021.08.053. Epub 2021 Aug 24. Chest. 2022. PMID: 34437887 Free PMC article. Review.
Cited by
-
The Upper Limit of Normal Rate of Lung Function Decline in Healthy Adults in the Framingham Heart Study.CHEST Pulm. 2024 Sep;2(3):100058. doi: 10.1016/j.chpulm.2024.100058. Epub 2024 Apr 15. CHEST Pulm. 2024. PMID: 39421758 Free PMC article.
-
Race-Based Pulmonary Function Testing Correction in COPD Inhaler Therapy Trials: A Systematic Review.Int J Chron Obstruct Pulmon Dis. 2024 Oct 12;19:2285-2297. doi: 10.2147/COPD.S475875. eCollection 2024. Int J Chron Obstruct Pulmon Dis. 2024. PMID: 39416876 Free PMC article. Review.
-
How do deep-learning models generalize across populations? Cross-ethnicity generalization of COPD detection.Insights Imaging. 2024 Aug 7;15(1):198. doi: 10.1186/s13244-024-01781-x. Insights Imaging. 2024. PMID: 39112910 Free PMC article.
-
Rethinking the Role of Race in Lung Function: The Shift to Race-Neutral Spirometry Interpretation.Mayo Clin Proc. 2024 Oct;99(10):1547-1552. doi: 10.1016/j.mayocp.2024.05.018. Epub 2024 Aug 2. Mayo Clin Proc. 2024. PMID: 39093270 No abstract available.
-
Lung Function and Brain MRI Outcomes in the Atherosclerosis Risk in Communities Neurocognitive Study.J Alzheimers Dis. 2024;100(1):297-308. doi: 10.3233/JAD-240162. J Alzheimers Dis. 2024. PMID: 38848187 Free PMC article.
Publication types
MeSH terms
Grants and funding
- T32HP10260/HRSA/HRSA HHS/United States
- 75N92020D00007/HL/NHLBI NIH HHS/United States
- N01HC95168/HL/NHLBI NIH HHS/United States
- N01HC95162/HL/NHLBI NIH HHS/United States
- R01-HL077612/HB/NHLBI NIH HHS/United States
- N01HC95165/HL/NHLBI NIH HHS/United States
- N01HC95167/HL/NHLBI NIH HHS/United States
- N01HC95159/HL/NHLBI NIH HHS/United States
- N01HC95163/HL/NHLBI NIH HHS/United States
- 75N92020D00002/HL/NHLBI NIH HHS/United States
- 75N92020D00003/HL/NHLBI NIH HHS/United States
- R01 HL130506/HL/NHLBI NIH HHS/United States
- N01HC95160/HL/NHLBI NIH HHS/United States
- R01-HL093081/HB/NHLBI NIH HHS/United States
- N01HC95169/HL/NHLBI NIH HHS/United States
- N01HC95161/HL/NHLBI NIH HHS/United States
- 75N92020D00001/HL/NHLBI NIH HHS/United States
- 75N92020D00005/HL/NHLBI NIH HHS/United States
- F32 HL158160/HL/NHLBI NIH HHS/United States
- 75N92020D00004/HL/NHLBI NIH HHS/United States
- UL1 TR001420/TR/NCATS NIH HHS/United States
- HHSN268201500003I/HL/NHLBI NIH HHS/United States
- N01HC95164/HL/NHLBI NIH HHS/United States
- UL1 TR001079/TR/NCATS NIH HHS/United States
- N01HC95166/HL/NHLBI NIH HHS/United States
- UL1 TR000040/TR/NCATS NIH HHS/United States
- K23 HL130627/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
